Cibc Bancorp Usa Inc. Fate Therapeutics Inc Transaction History
Cibc Bancorp Usa Inc.
- $80.8 Billion
- Q3 2025
A detailed history of Cibc Bancorp Usa Inc. transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Cibc Bancorp Usa Inc. holds 11,593 shares of FATE stock, worth $12,984. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,593Holding current value
$12,984% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding FATE
# of Institutions
157Shares Held
80.1MCall Options Held
159KPut Options Held
13.4K-
Redmile Group, LLC San Francisco, CA12.9MShares$14.4 Million1.75% of portfolio
-
Black Rock Inc. New York, NY10.1MShares$11.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.8MShares$9.85 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.54MShares$5.09 Million0.0% of portfolio
-
Johnson & Johnson New Brunswick, NJ3.38MShares$3.78 Million1.0% of portfolio
About FATE THERAPEUTICS INC
- Ticker FATE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,000,304
- Market Cap $109M
- Description
- Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...